From music rhythms to treat multiple sclerosis patients to predicting COVID-19 variants, each week we highlight five things to know in life sciences. … READ MORE >
biotech
5 things to know in life sciences: Week of May 2, 2022
From a series of moves by the FDA to sentiment in the biotech funding space, each week we highlight five things to know in life sciences. … READ MORE >
5 things to know in life sciences: Week of March 28, 2022
From a brain interface device to promising trial results for a potential opioid alternative, each week we highlight five things to know in life sciences. … READ MORE >
5 things to know in life sciences: Week of Feb. 7, 2022
From regulatory challenges to a cartilage implant inspired by spiders, each week we highlight five things to know in the life sciences industry. … READ MORE >
Macroeconomic drivers for life sciences: Spring 2022 outlook
For the life sciences ecosystem to continue to thrive, leaders must reevaluate their operating environment and plan for key drivers this year. … READ MORE >
5 things to know in life sciences: Week of October 11
Each week we highlight five things you need to know in the life sciences industry. … READ MORE >
5 things to know in life sciences: Week of July 26
From the development of an insulin biosimilar to a new tool matching mental health providers with patients, each week we highlight five things you need to know in the life sciences industry. … READ MORE >
5 things to know in life sciences: Week of March 29
From biopharma merger scrutiny to AI-powered biology research, we highlight what’s happening in the life sciences industry this week. … READ MORE >
5 things to know in life sciences: Week of Feb. 15
In this week’s roundup we look at promising results in a clinical trial leveraging an existing diabetes drug to treat obesity, a new and less invasive treatment for sleep apnea, the impact of the pandemic on oncology trials and more. … READ MORE >
5 things to know in life sciences: Week of Feb. 8
Recent industry news includes the impact of new COVID-19 variants on existing vaccines for the disease, the outlook for drug pricing reforms under the Biden administration, and the promise of 3D-printed hearts. … READ MORE >